West Pharmaceutical Services (WST) Operating Expenses (2016 - 2025)
Historic Operating Expenses for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $128.8 million.
- West Pharmaceutical Services' Operating Expenses rose 2408.48% to $128.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $467.9 million, marking a year-over-year increase of 1479.39%. This contributed to the annual value of $467.9 million for FY2025, which is 1479.39% up from last year.
- Latest data reveals that West Pharmaceutical Services reported Operating Expenses of $128.8 million as of Q4 2025, which was up 2408.48% from $119.8 million recorded in Q3 2025.
- In the past 5 years, West Pharmaceutical Services' Operating Expenses ranged from a high of $128.8 million in Q4 2025 and a low of $79.9 million during Q3 2022
- Over the past 5 years, West Pharmaceutical Services' median Operating Expenses value was $104.3 million (recorded in 2024), while the average stood at $104.4 million.
- Its Operating Expenses has fluctuated over the past 5 years, first tumbled by 2390.48% in 2022, then soared by 3191.49% in 2023.
- West Pharmaceutical Services' Operating Expenses (Quarter) stood at $111.7 million in 2021, then dropped by 9.04% to $101.6 million in 2022, then grew by 6.69% to $108.4 million in 2023, then dropped by 4.24% to $103.8 million in 2024, then grew by 24.08% to $128.8 million in 2025.
- Its Operating Expenses was $128.8 million in Q4 2025, compared to $119.8 million in Q3 2025 and $115.0 million in Q2 2025.